Paper17599042
Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models.
Desnoyers LR and 11 others. Oncogene, 2008. Cited by 226 papers, by iCite.
Cite this record
ConductScience Library. Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models. Papers, record 17599042. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17599042
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Blocking | Major topic |
| Antineoplastic Agents | Major topic |
| Carcinoma, Hepatocellular | Major topic |
| Colonic Neoplasms | Major topic |
| Fibroblast Growth Factors | Major topic |
| Gene Targeting | Major topic |
| Liver Neoplasms, Experimental | Major topic |
| Xenograft Model Antitumor Assays | Major topic |
| Animals | |
| Antibodies, Monoclonal | |
| Carcinoma, Squamous Cell | |
| HCT116 Cells | |
| HT29 Cells | |
| Humans | |
| Lung Neoplasms | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Nude | |
| Mice, Transgenic | |
| Neoplasm Transplantation | |
| Receptor, Fibroblast Growth Factor, Type 4 | |
| Transplantation, Heterologous |
Source PubMed
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9354676 | A novel chromosomal translocation t(4; 14)(p16.3; q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene. | Blood | 1997 | https://conductscience.org/library/papers/9354676 | PubMed |
| 2 | 11325814 | Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers. | Cancer Res | 2001 | https://conductscience.org/library/papers/11325814 | PubMed |
| 3 | 1311251 | PDGF alpha- and beta-receptors activate unique and common signal transduction pathways. | EMBO J | 1992 | https://conductscience.org/library/papers/1311251 | PubMed |
| 4 | 11358849 | Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells. | Cancer Res | 2001 | https://conductscience.org/library/papers/11358849 | PubMed |
| 5 | 15655558 | Evaluation of the fibroblast growth factor system as a potential target for therapy in human prostate cancer. | Br J Cancer | 2005 | https://conductscience.org/library/papers/15655558 | PubMed |
| 6 | 11236938 | FGF-2 abnormalities in B cell chronic lymphocytic and chronic myeloid leukemias. | Leukemia | 2001 | https://conductscience.org/library/papers/11236938 | PubMed |
| 7 | 15070963 | Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: relation to tumor type, size, proliferation, and invasiveness. | J Clin Endocrinol Metab | 2004 | https://conductscience.org/library/papers/15070963 | PubMed |
| 8 | 224200 | Precancerous changes in the human liver. | J Toxicol Environ Health | 1979 | https://conductscience.org/library/papers/224200 | PubMed |
| 9 | 8099571 | Amplification of fgfr4 gene in human breast and gynecological cancers. | Int J Cancer | 1993 | https://conductscience.org/library/papers/8099571 | PubMed |
| 10 | 12223061 | Fibroblast growth factors in cancer: therapeutic possibilities. | Expert Opin Ther Targets | 2002 | https://conductscience.org/library/papers/12223061 | PubMed |
| 11 | 14559787 | Involvement of the FGF18 gene in colorectal carcinogenesis, as a novel downstream target of the beta-catenin/T-cell factor complex. | Cancer Res | 2003 | https://conductscience.org/library/papers/14559787 | PubMed |
| 12 | 8663044 | Receptor specificity of the fibroblast growth factor family. | J Biol Chem | 1996 | https://conductscience.org/library/papers/8663044 | PubMed |
| 13 | 15448004 | The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression. | Clin Cancer Res | 2004 | https://conductscience.org/library/papers/15448004 | PubMed |
| 14 | 11418238 | Identification of a new fibroblast growth factor receptor, FGFR5. | Gene | 2001 | https://conductscience.org/library/papers/11418238 | PubMed |
| 15 | 11157491 | Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma. | Blood | 2001 | https://conductscience.org/library/papers/11157491 | PubMed |
| 16 | 10786811 | FGF4 and INT2 oncogenes are amplified and expressed in Kaposi's sarcoma. | Mod Pathol | 2000 | https://conductscience.org/library/papers/10786811 | PubMed |
| 17 | 11276432 | Fibroblast growth factors. | Genome Biol | 2001 | https://conductscience.org/library/papers/11276432 | PubMed |
| 18 | 14648664 | High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer. | J Pathol | 2003 | https://conductscience.org/library/papers/14648664 | PubMed |
| 19 | 11021964 | Fibroblast growth factors, their receptors and signaling. | Endocr Relat Cancer | 2000 | https://conductscience.org/library/papers/11021964 | PubMed |
| 20 | 9114106 | CT depiction of experimental liver tumors: contrast enhancement with hepatocyte-selective iodinated triglyceride versus conventional techniques. | Radiology | 1997 | https://conductscience.org/library/papers/9114106 | PubMed |
Cited by127
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 226 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42687197 | Neutrophil extracellular traps in colorectal cancer: context-dependent roles from inflammatory carcinogenesis to liver metastasis and therapeutic targeting. | J Transl Med | 2026 | https://conductscience.org/library/papers/42687197 | PubMed |
| 42633326 | Advances in FGF/FGFR Signaling: Implications for Disease and Therapy. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42633326 | PubMed |
| 42491058 | The role of FGF19-FGFR4 signaling pathway in liver health and disease: Guardian or destroyer. | Genes Dis | 2026 | https://conductscience.org/library/papers/42491058 | PubMed |
| 41681889 | Targeting Colorectal Cancer Stem Cells Through Inhibition of the Fibroblast Growth Factor Receptor 4 Pathway with a Novel Antibody. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41681889 | PubMed |
| 41631414 | Colorectal cancer-derived FGF19 is a metabolically active serum biomarker that exerts enteroendocrine effects on mouse liver. | Mol Oncol | 2026 | https://conductscience.org/library/papers/41631414 | PubMed |
| 41328353 | FGF19 in Solid Tumors: Molecular Mechanisms, Metabolic Reprogramming, and Emerging Therapeutic Opportunities. | Theranostics | 2026 | https://conductscience.org/library/papers/41328353 | PubMed |
| 41097083 | Reactivation of the PI3K/mTOR Signaling Pathway Confers Resistance to the FGFR4 Inhibitor FGF401. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41097083 | PubMed |
| 40879845 | KLB as a potential prognostic biomarker and therapeutic target in colorectal cancer: insights from multi omics and single cell analyses. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40879845 | PubMed |
| 40205008 | FGFR as a Predictive Marker for Targeted Therapy in Gastrointestinal Malignancies: A Systematic Review. | J Gastrointest Cancer | 2025 | https://conductscience.org/library/papers/40205008 | PubMed |
| 39957843 | Farnesoid X receptor and fibroblast growth factor 15/19 as pharmacological targets. | Liver Res | 2021 | https://conductscience.org/library/papers/39957843 | PubMed |
| 39915447 | Hepatocellular carcinoma: signaling pathways and therapeutic advances. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/39915447 | PubMed |
| 38238100 | Circadian Regulation of Endocrine Fibroblast Growth Factors on Systemic Energy Metabolism. | Mol Pharmacol | 2024 | https://conductscience.org/library/papers/38238100 | PubMed |
| 38212977 | Targeting the FGF19-FGFR4 pathway for cholestatic, metabolic, and cancerous diseases. | J Intern Med | 2024 | https://conductscience.org/library/papers/38212977 | PubMed |
| 37108717 | Exploring the Structural and Functional Diversity among FGF Signals: A Comparative Study of Human, Mouse, and Xenopus FGF Ligands in Embryonic Development and Cancer Pathogenesis. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37108717 | PubMed |
| 36923538 | FGF19-mediated ELF4 overexpression promotes colorectal cancer metastasis through transactivating FGFR4 and SRC. | Theranostics | 2023 | https://conductscience.org/library/papers/36923538 | PubMed |
| 36624801 | Hepatocellular Carcinoma: Current Therapeutic Algorithm for Localized and Advanced Disease. | J Oncol | 2022 | https://conductscience.org/library/papers/36624801 | PubMed |
| 36622048 | Phase 1 dose escalation study of FGFR4 inhibitor in combination with pembrolizumab in advanced solid tumors patients. | Cancer Med | 2023 | https://conductscience.org/library/papers/36622048 | PubMed |
| 36581900 | Interactions of melatonin with various signaling pathways: implications for cancer therapy. | Cancer Cell Int | 2022 | https://conductscience.org/library/papers/36581900 | PubMed |
| 36450103 | Multiomics of Colorectal Cancer Organoids Reveals Putative Mediators of Cancer Progression Resulting from SMAD4 Inactivation. | J Proteome Res | 2023 | https://conductscience.org/library/papers/36450103 | PubMed |
| 36288716 | Isoform-specific inhibition of FGFR signaling achieved by a de-novo-designed mini-protein. | Cell Rep | 2022 | https://conductscience.org/library/papers/36288716 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CTNNB1 | 1499 | PubTator's text mining | https://conductscience.org/library/genes/1499 | NCBI Gene |
| FGF19 | 9965 | PubTator's text mining | https://conductscience.org/library/genes/9965 | NCBI Gene |
| FGFR4 | 2264 | PubTator's text mining | https://conductscience.org/library/genes/2264 | NCBI Gene |
| FRS2 | 10818 | PubTator's text mining | https://conductscience.org/library/genes/10818 | NCBI Gene |
| MAPK1 | 5594 | PubTator's text mining | https://conductscience.org/library/genes/5594 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17599042
GET https://conductscience.org/api/papers/v1/17599042/references?page=2